Paulson Wealth Management Inc. Has $2.08 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Paulson Wealth Management Inc. trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,551 shares of the healthcare conglomerate’s stock after selling 50 shares during the quarter. UnitedHealth Group makes up about 0.6% of Paulson Wealth Management Inc.’s portfolio, making the stock its 28th largest holding. Paulson Wealth Management Inc.’s holdings in UnitedHealth Group were worth $2,076,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. China Universal Asset Management Co. Ltd. increased its position in UnitedHealth Group by 20.6% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock valued at $5,376,000 after purchasing an additional 1,857 shares during the period. Quent Capital LLC lifted its holdings in UnitedHealth Group by 5.5% in the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock valued at $2,076,000 after buying an additional 217 shares during the period. Fortis Capital Advisors LLC bought a new position in shares of UnitedHealth Group in the 1st quarter worth about $236,000. Charles Schwab Investment Advisory Inc. lifted its stake in UnitedHealth Group by 17.5% in the first quarter. Charles Schwab Investment Advisory Inc. now owns 484 shares of the healthcare conglomerate’s stock valued at $240,000 after buying an additional 72 shares during the period. Finally, Delta Investment Management LLC increased its stake in shares of UnitedHealth Group by 22.5% in the 1st quarter. Delta Investment Management LLC now owns 522 shares of the healthcare conglomerate’s stock valued at $258,000 after acquiring an additional 96 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on UNH. Barclays reduced their price target on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. HSBC lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Argus lifted their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Truist Financial reaffirmed a “buy” rating and issued a $625.00 price objective (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Finally, Stephens decreased their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Stock Down 1.6 %

Shares of NYSE UNH opened at $615.01 on Wednesday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The business’s fifty day moving average price is $582.63 and its 200-day moving average price is $546.78. The stock has a market capitalization of $565.98 billion, a PE ratio of 40.07, a P/E/G ratio of 1.84 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same quarter in the previous year, the firm posted $6.56 earnings per share. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.37%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.